Characteristic actions of CDP-choline on the central nervous system.
D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D001143:Arousal / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D001933:Brain Stem / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D002794:Choline / Q000494:pharmacology*; D003597:Cytosine Nucleotides / Q000494:pharmacology*; D004569:Electroencephalography; D004576:Electromyography; D005071:Evoked Potentials / Q000187:drug effects; D005552:Forelimb / Q000187:drug effects; D006614:Hindlimb / Q000187:drug effects; D006624:Hippocampus / Q000187:drug effects; D008839:Microelectrodes; D009132:Muscles / Q000187:drug effects; D009474:Neurons / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D011712:Pyramidal Tracts / Q000187:drug effects; D011817:Rabbits; D012154:Reticular Formation / Q000187:drug effects; D013238:Stereotaxic Techniques
D003597:Cytosine Nucleotides; D000661:Amphetamine; D002794:Choline; D010433:Pentylenetetrazole